Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Sodium Gel 1% for Acute Delayed Onset Muscle Soreness
NCT02271854Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in delayed onset muscle soreness (DOMS) comparing Diclofenac Sodium Gel 1% with Placebo Gel (2 arms). Primary endpoint: Sum of Pain Intensity Differences Over 24 Hours After Initiating Treatment. Started Oct 2014; status: completed.
02
Drugs
diclofenac sodium
03
Conditions
delayed onset muscle soreness (DOMS)
Beyond the preview
Go deeper on NCT02271854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02271854.